{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:47:09Z","timestamp":1791071229749,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11124-8","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:32:50Z","timestamp":1760070770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The gut immune axis in ulcerative colitis: insights from microbiome research"],"prefix":"10.1007","volume":"52","author":[{"given":"Rufaida","family":"Wasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"10","key":"11124_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG (2023) Ulcerative colitis in adults: a review. JAMA 330(10):951\u2013965","journal-title":"JAMA"},{"issue":"4","key":"11124_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000496739","volume":"37","author":"S Danese","year":"2019","unstructured":"Danese S, Allez M, van Bodegraven AA, Dotan I, Gisbert JP, Hart A, Lakatos PL, Magro F, Peyrin-Biroulet L, Schreiber S, Tarabar D (2019) Unmet medical needs in ulcerative colitis: an expert group consensus. Dig Dis 37(4):266\u2013283","journal-title":"Dig Dis"},{"issue":"1","key":"11124_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12876-020-01296-x","volume":"20","author":"I Zammarchi","year":"2020","unstructured":"Zammarchi I, Lanzarotto F, Cannatelli R, Munari F, Benini F, Pozzi A, Lanzini A, Ricci C (2020) Elderly-onset vs adult-onset ulcerative colitis: a different natural history? BMC Gastroenterol 20(1):147","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"11124_CR4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/jcm11020400","volume":"11","author":"A Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna A, Olczyk P, Komosi\u0144ska-Vassev K (2022) The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J Clin Med 11(2):400","journal-title":"J Clin Med"},{"key":"11124_CR5","doi-asserted-by":"crossref","unstructured":"Wasim R, Ahmad A, Anwar A, Salman A (2025) Microbial imbalance in the gut: a new frontier in rheumatoid arthritis research. Inflammopharmacology 1\u201315","DOI":"10.1007\/s10787-025-01737-7"},{"issue":"3","key":"11124_CR6","first-page":"247","volume":"15","author":"EP Halmos","year":"2024","unstructured":"Halmos EP, Godny L, Vanderstappen J, Sarbagili-Shabat C, Svolos V (2024) Role of diet in prevention versus treatment of Crohn\u2019s disease and ulcerative colitis. Frontline Gastroenterol 15(3):247\u2013257","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"11124_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB (2022) The gut microbiome and inflammatory bowel diseases. Annu Rev Med 73(1):455\u2013468","journal-title":"Annu Rev Med"},{"key":"11124_CR8","doi-asserted-by":"crossref","first-page":"155564","DOI":"10.1016\/j.phymed.2024.155564","volume":"129","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Zhu X, Shen J, Chen H, Zhou G (2024) Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect in ulcerative colitis. Phytomedicine 129:155564","journal-title":"Phytomedicine"},{"key":"11124_CR9","doi-asserted-by":"crossref","first-page":"691480","DOI":"10.3389\/fimmu.2021.691480","volume":"12","author":"S Bruscoli","year":"2021","unstructured":"Bruscoli S, Febo M, Riccardi C, Migliorati G (2021) Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice. Front Immunol 12:691480","journal-title":"Front Immunol"},{"key":"11124_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00014-21","author":"J Zou","year":"2021","unstructured":"Zou J, Liu C, Jiang S, Qian D, Duan J (2021) Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis. Infect Immun. https:\/\/doi.org\/10.1128\/IAI.00014-21","journal-title":"Infect Immun"},{"issue":"10","key":"11124_CR11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","volume":"15","author":"F Sommer","year":"2017","unstructured":"Sommer F, Anderson JM, Bharti R, Raes J, Rosenstiel P (2017) The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol 15(10):630\u2013638","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"11124_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","volume":"24","author":"ZH Shen","year":"2018","unstructured":"Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY (2018) Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 24(1):5","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11124_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A (2018) Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol 11(1):1\u20130","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"11124_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12876-019-0930-3","volume":"19","author":"LY Pei","year":"2019","unstructured":"Pei LY, Ke YS, Zhao HH, Wang L, Jia C, Liu WZ, Fu QH, Shi MN, Cui J, Li SC (2019) Role of colonic microbiota in the pathogenesis of ulcerative colitis. BMC Gastroenterol 19(1):10","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"11124_CR15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823\u20131836","journal-title":"Biochem J"},{"issue":"4","key":"11124_CR16","first-page":"10","volume":"11","author":"EC Soto-Martin","year":"2020","unstructured":"Soto-Martin EC, Warnke I, Farquharson FM, Christodoulou M, Horgan G, Derrien M, Faurie JM, Flint HJ, Duncan SH, Louis P (2020) Vitamin biosynthesis by human gut butyrate-producing bacteria and cross-feeding in synthetic microbial communities. MBio 11(4):10\u2013128","journal-title":"MBio"},{"key":"11124_CR17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fimmu.2019.00607","volume":"10","author":"HY Cheng","year":"2019","unstructured":"Cheng HY, Ning MX, Chen DK, Ma WT (2019) Interactions between the gut microbiota and the host innate immune response against pathogens. Front Immunol 10:607","journal-title":"Front Immunol"},{"issue":"1","key":"11124_CR18","doi-asserted-by":"crossref","first-page":"2041342","DOI":"10.1080\/19490976.2022.2041342","volume":"14","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Maynard CL (2022) Mucus, commensals, and the immune system. Gut Microbes 14(1):2041342","journal-title":"Gut Microbes"},{"key":"11124_CR19","doi-asserted-by":"crossref","first-page":"594806","DOI":"10.3389\/fcimb.2020.594806","volume":"10","author":"W Su","year":"2020","unstructured":"Su W, Chen Y, Cao P, Chen Y, Guo Y, Wang S, Dong W (2020) Fusobacterium nucleatum promotes the development of ulcerative colitis by inducing the autophagic cell death of intestinal epithelial. Front Cell Infect Microbiol 10:594806","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"11124_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/path.5358","volume":"250","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chen Y, Cao P, Su W, Zhan N, Dong W (2020) Fusobacterium nucleatum facilitates ulcerative colitis through activating IL-17F signaling to NF\u2010\u03baB via the upregulation of CARD3 expression. J Pathol 250(2):170\u2013182","journal-title":"J Pathol"},{"issue":"7","key":"11124_CR21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/biomedicines11071979","volume":"11","author":"N Dovrolis","year":"2023","unstructured":"Dovrolis N, Moschoviti A, Fessatou S, Karamanolis G, Kolios G, Gazouli M (2023) Identifying microbiome dynamics in pediatric IBD: more than a family matter. Biomedicines 11(7):1979","journal-title":"Biomedicines"},{"issue":"7758","key":"11124_CR22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, Casero D (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569(7758):655\u2013662","journal-title":"Nature"},{"issue":"4","key":"11124_CR23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","volume":"158","author":"R Pittayanon","year":"2020","unstructured":"Pittayanon R, Lau JT, Leontiadis GI, Tse F, Yuan Y, Surette M, Moayyedi P (2020) Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review. Gastroenterology 158(4):930\u2013946","journal-title":"Gastroenterology"},{"key":"11124_CR24","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","volume":"9","author":"T Zuo","year":"2018","unstructured":"Zuo T, Ng SC (2018) The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol 9:2247","journal-title":"Front Microbiol"},{"issue":"2","key":"11124_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, Sauk JS (2019) Gut Microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol 4(2):293\u2013305","journal-title":"Nat Microbiol"},{"issue":"3","key":"11124_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","volume":"8","author":"I Khan","year":"2019","unstructured":"Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C (2019) Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8(3):126","journal-title":"Pathogens"},{"issue":"5","key":"11124_CR27","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s12276-021-00617-8","volume":"53","author":"J Fang","year":"2021","unstructured":"Fang J, Wang H, Zhou Y, Zhang H, Zhou H, Zhang X (2021) Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis. Exp Mol Med 53(5):772\u2013787","journal-title":"Exp Mol Med"},{"issue":"1","key":"11124_CR28","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1831339","volume":"12","author":"WF Van Zyl","year":"2020","unstructured":"Van Zyl WF, Deane SM, Dicks LM (2020) Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria. Gut Microbes 12(1):1831339","journal-title":"Gut Microbes"},{"issue":"4","key":"11124_CR29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12298-024-01452-7","volume":"30","author":"Z Nabi","year":"2024","unstructured":"Nabi Z, Manzoor S, Nabi SU, Wani TA, Gulzar H, Farooq M, Arya VM, Baloch FS, Vl\u0103dulescu C, Popescu SM, Mansoor S (2024) Pattern-triggered immunity and effector-triggered immunity: crosstalk and cooperation of PRR and NLR-mediated plant defense pathways during host\u2013pathogen interactions. Physiol Mol Biol Plants 30(4):587\u2013604","journal-title":"Physiol Mol Biol Plants"},{"issue":"4","key":"11124_CR30","doi-asserted-by":"crossref","first-page":"151715","DOI":"10.1016\/j.acthis.2021.151715","volume":"123","author":"S Pergolizzi","year":"2021","unstructured":"Pergolizzi S, Rizzo G, Favaloro A, Alesci A, Pallio S, Melita G, Cutroneo G, Lauriano ER (2021) Expression of VAChT and 5-HT in ulcerative colitis dendritic cells. Acta Histochem 123(4):151715","journal-title":"Acta Histochem"},{"issue":"1","key":"11124_CR31","volume":"2022","author":"D Sun","year":"2022","unstructured":"Sun D, Li C, Chen S, Zhang X (2022) Emerging role of dendritic cell intervention in the treatment of inflammatory bowel disease. BioMed Res Int 2022(1):7025634","journal-title":"BioMed Res Int"},{"issue":"1","key":"11124_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12934-022-01812-6","volume":"21","author":"L Liang","year":"2022","unstructured":"Liang L, Yang C, Liu L, Mai G, Li H, Wu L, Jin M, Chen Y (2022) Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota. Microb Cell Fact 21(1):88","journal-title":"Microb Cell Fact"},{"issue":"4","key":"11124_CR33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jcmgh.2020.05.007","volume":"10","author":"R Sun","year":"2020","unstructured":"Sun R, Abraham C (2020) IL23 promotes antimicrobial pathways in human macrophages, which are reduced with the IBD-protective IL23R R381Q variant. Cell Mol Gastroenterol Hepatol 10(4):673\u2013697","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"11124_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40168-022-01275-2","volume":"10","author":"A Sinha","year":"2022","unstructured":"Sinha A, Li Y, Mirzaei MK, Shamash M, Samadfam R, King IL, Maurice CF (2022) Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis. Microbiome 10(1):105","journal-title":"Microbiome"},{"issue":"12","key":"11124_CR35","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/microorganisms8122012","volume":"8","author":"M \u0141usiak-Szelachowska","year":"2020","unstructured":"\u0141usiak-Szelachowska M, Weber-D\u0105browska B, \u017baczek M, Borysowski J, G\u00f3rski A (2020) The presence of bacteriophages in the human body: good, bad or neutral? Microorganisms 8(12):2012","journal-title":"Microorganisms"},{"issue":"13","key":"11124_CR36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311217","volume":"24","author":"V Andersen","year":"2023","unstructured":"Andersen V, Bennike TB, Bang C, Rioux JD, H\u00e9bert-Milette I, Sato T, Hansen AK, Nielsen OH (2023) Investigating the crime scene\u2014Molecular signatures in inflammatory bowel disease. Int J Mol Sci 24(13):11217","journal-title":"Int J Mol Sci"},{"issue":"10","key":"11124_CR37","volume":"8","author":"JY Yoo","year":"2020","unstructured":"Yoo JY, Groer M, Dutra SV, Sarkar A, McSkimming DI (2020) Gut microbiota and immune system interactions. Microorganisms 8(10):1587","journal-title":"Microorganisms"},{"issue":"1","key":"11124_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","volume":"145","author":"KL Glassner","year":"2020","unstructured":"Glassner KL, Abraham BP, Quigley EM (2020) The microbiome and inflammatory bowel disease. J Allergy Clin Immunol 145(1):16\u201327","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"11124_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270242","volume":"17","author":"R Yoshikata","year":"2022","unstructured":"Yoshikata R, Yamaguchi M, Mase Y, Tatsuyuki A, Myint KZ, Ohta H (2022) Evaluation of the efficacy of Lactobacillus-containing feminine hygiene products on vaginal microbiome and genitourinary symptoms in pre-and postmenopausal women: a pilot randomized controlled trial. PLoS ONE 17(12):e0270242","journal-title":"PLoS ONE"},{"issue":"9","key":"11124_CR40","volume":"118","author":"Q Mu","year":"2021","unstructured":"Mu Q, Swartwout BK, Edwards M, Zhu J, Lee G, Eden K, Cabana-Puig X, McDaniel DK, Mao J, Abdelhamid L, Brock RM (2021) Regulation of neonatal IgA production by the maternal microbiota. Proc Natl Acad Sci U S A 118(9):e2015691118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"11124_CR41","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9120398","volume":"9","author":"NM Elemam","year":"2017","unstructured":"Elemam NM, Hannawi S, Maghazachi AA (2017) Innate lymphoid cells (ILCs) as mediators of inflammation, release of cytokines and lytic molecules. Toxins 9(12):398","journal-title":"Toxins"},{"key":"11124_CR42","doi-asserted-by":"crossref","first-page":"600973","DOI":"10.3389\/fimmu.2020.600973","volume":"11","author":"C Cosovanu","year":"2020","unstructured":"Cosovanu C, Neumann C (2020) The many functions of Foxp3\u2009+\u2009regulatory T cells in the intestine. Front Immunol 11:600973","journal-title":"Front Immunol"},{"key":"11124_CR43","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3389\/fmicb.2017.02100","volume":"8","author":"M Toscano","year":"2017","unstructured":"Toscano M, De Grandi R, Grossi E, Drago L (2017) Role of the human breast milk-associated microbiota on the newborns\u2019 immune system: a mini review. Front Microbiol 8:2100","journal-title":"Front Microbiol"},{"issue":"12","key":"11124_CR44","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.3390\/nu12123783","volume":"12","author":"K \u0141ubiech","year":"2020","unstructured":"\u0141ubiech K, Twaru\u017cek M (2020) Lactobacillus bacteria in breast milk. Nutrients 12(12):3783","journal-title":"Nutrients"},{"issue":"24","key":"11124_CR45","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.3390\/nu15245103","volume":"15","author":"B Bertin","year":"2023","unstructured":"Bertin B, Foligne B, Ley D, Lesage J, Beghin L, Morcel J, Gottrand F, Hermann E (2023) An overview of the influence of breastfeeding on the development of inflammatory bowel disease. Nutrients 15(24):5103","journal-title":"Nutrients"},{"issue":"9","key":"11124_CR46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.14291","volume":"46","author":"L Xu","year":"2017","unstructured":"Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN (2017) Systematic review with meta-analysis: breastfeeding and the risk of Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther 46(9):780\u2013789","journal-title":"Aliment Pharmacol Ther"},{"key":"11124_CR47","doi-asserted-by":"crossref","first-page":"1051368","DOI":"10.3389\/falgy.2022.1051368","volume":"3","author":"MR Perkin","year":"2022","unstructured":"Perkin MR, Strachan DP (2022) The hygiene hypothesis for allergy\u2013conception and evolution. Front Allergy 3:1051368","journal-title":"Front Allergy"},{"issue":"05","key":"11124_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0040-1716724","volume":"30","author":"A Mutanen","year":"2020","unstructured":"Mutanen A, Pakarinen MP (2020) Perianal Crohn\u2019s disease in children and adolescents. Eur J Pediatr Surg 30(05):395\u2013400","journal-title":"Eur J Pediatr Surg"},{"issue":"9","key":"11124_CR49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/MIB.0000000000000852","volume":"22","author":"A Cholapranee","year":"2016","unstructured":"Cholapranee A, Ananthakrishnan AN (2016) Environmental hygiene and risk of inflammatory bowel diseases: a systematic review and meta-analysis. Inflamm Bowel Dis 22(9):2191\u20132199","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"11124_CR50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/apt.16703","volume":"55","author":"M Zhao","year":"2022","unstructured":"Zhao M, Feng R, Ben-Horin S, Zhuang X, Tian Z, Li X, Ma R, Mao R, Qiu Y, Chen M (2022) Systematic review with meta\u2010analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Aliment Pharmacol Ther 55(3):266\u2013276","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"11124_CR51","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/17474124.2021.1940956","volume":"15","author":"CM Verburgt","year":"2021","unstructured":"Verburgt CM, Heutink WP, Kuilboer LI, Dickmann JD, van Etten-Jamaludin FS, Benninga MA, de Jonge WJ, Van Limbergen JE, Tabbers MM (2021) Antibiotics in pediatric inflammatory bowel diseases: a systematic review. Expert Rev Gastroenterol Hepatol 15(8):891\u2013907","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"11124_CR52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","volume":"23","author":"D Ishikawa","year":"2017","unstructured":"Ishikawa D, Sasaki T, Osada T, Kuwahara-Arai K, Haga K, Shibuya T, Hiramatsu K, Watanabe S (2017) Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm Bowel Dis 23(1):116\u2013125","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"11124_CR53","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","volume":"109","author":"R Ungaro","year":"2014","unstructured":"Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho KL, Kronman MP, Shaw S, Van Kruiningen H, Colombel JF, Atreja A (2014) Antibiotics associated with increased risk of new-onset Crohn\u2019s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 109(11):1728\u20131738","journal-title":"Am J Gastroenterol"},{"key":"11124_CR54","doi-asserted-by":"crossref","first-page":"733992","DOI":"10.3389\/fcimb.2022.733992","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y (2022) The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol 12:733992","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"11124_CR55","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia S, Virmani S, Vuyyuru SK, Kumar P, Kante B, Sahu P, Kaushal K, Farooqui M, Singh M, Verma M, Bajaj A (2022) Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 71(12):2401\u20132413","journal-title":"Gut"},{"issue":"2","key":"11124_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.chom.2019.06.013","volume":"26","author":"JE Bisanz","year":"2019","unstructured":"Bisanz JE, Upadhyay V, Turnbaugh JA, Ly K, Turnbaugh PJ (2019) Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet. Cell Host Microbe 26(2):265\u2013272","journal-title":"Cell Host Microbe"},{"issue":"6","key":"11124_CR57","volume":"132","author":"O Kaczmarczyk","year":"2022","unstructured":"Kaczmarczyk O, D\u0105bek-Drobny A, Wo\u017aniakiewicz M, Pa\u015bko P, Pi\u0105tek-Guziewicz A, Zwoli\u0144ska-Wcis\u0142o M (2022) Altered fecal short-chain fatty acid profile as a potential marker of disease activity in patients with ulcerative colitis and crohn\u2019s disease: a pilot study. Pol Archives Intern Med 132(6):16254","journal-title":"Pol Archives Intern Med"},{"issue":"18","key":"11124_CR58","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/foods11182863","volume":"11","author":"RG Xiong","year":"2022","unstructured":"Xiong RG, Zhou DD, Wu SX, Huang SY, Saimaiti A, Yang ZJ, Shang A, Zhao CN, Gan RY, Li HB (2022) Health benefits and side effects of short-chain fatty acids. Foods 11(18):2863","journal-title":"Foods"},{"issue":"1","key":"11124_CR59","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41598-022-07176-6","volume":"12","author":"TA Houtman","year":"2022","unstructured":"Houtman TA, Eckermann HA, Smidt H, de Weerth C (2022) Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers. Sci Rep 12(1):3140","journal-title":"Sci Rep"},{"issue":"3","key":"11124_CR60","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/jhn.12544","volume":"31","author":"S Rashvand","year":"2018","unstructured":"Rashvand S, Behrooz M, Samsamikor M, Jacobson K, Hekmatdoost A (2018) Dietary patterns and risk of ulcerative colitis: a case\u2013control study. J Hum Nutr Diet 31(3):408\u2013412","journal-title":"J Hum Nutr Diet"},{"issue":"7","key":"11124_CR61","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/nu11071498","volume":"11","author":"AH Keshteli","year":"2019","unstructured":"Keshteli AH, Madsen KL, Dieleman LA (2019) Diet in the pathogenesis and management of ulcerative colitis; a review of randomized controlled dietary interventions. Nutrients 11(7):1498","journal-title":"Nutrients"},{"issue":"11","key":"11124_CR62","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/gutjnl-2017-314968","volume":"67","author":"H Watson","year":"2018","unstructured":"Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, Dye L (2018) A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut 67(11):1974\u20131983","journal-title":"Gut"},{"issue":"49","key":"11124_CR63","volume":"96","author":"JY Nie","year":"2017","unstructured":"Nie JY, Zhao Q (2017) Beverage consumption and risk of ulcerative colitis: systematic review and meta-analysis of epidemiological studies. Medicine (Baltimore) 96(49):e9070","journal-title":"Medicine (Baltimore)"},{"key":"11124_CR64","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.606298","volume":"7","author":"J Sankarasubramanian","year":"2020","unstructured":"Sankarasubramanian J, Ahmad R, Avuthu N, Singh AB, Guda C (2020) Gut microbiota and metabolic specificity in ulcerative colitis and crohn\u2019s disease. Front Med 7:606298","journal-title":"Front Med"},{"issue":"1","key":"11124_CR65","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1038\/s41598-022-11860-y","volume":"12","author":"BC Chen","year":"2022","unstructured":"Chen BC, Weng MT, Chang CH, Huang LY, Wei SC (2022) Effect of smoking on the development and outcomes of inflammatory bowel disease in Taiwan: a hospital-based cohort study. Sci Rep 12(1):7665","journal-title":"Sci Rep"},{"key":"11124_CR66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2018.00074","volume":"9","author":"L Berkowitz","year":"2018","unstructured":"Berkowitz L, Schultz BM, Salazar GA, Pardo-Roa C, Sebasti\u00e1n VP, \u00c1lvarez-Lobos MM, Bueno SM (2018) Impact of cigarette smoking on the gastrointestinal tract inflammation: opposing effects in Crohn\u2019s disease and ulcerative colitis. Front Immunol 9:74","journal-title":"Front Immunol"},{"issue":"8","key":"11124_CR67","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.crohns.2014.02.002","volume":"8","author":"GC Parkes","year":"2014","unstructured":"Parkes GC, Whelan K, Lindsay JO (2014) Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 8(8):717\u2013725","journal-title":"J Crohns Colitis"},{"issue":"5","key":"11124_CR68","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apt.15390","volume":"50","author":"J Blackwell","year":"2019","unstructured":"Blackwell J, Saxena S, Alexakis C, Bottle A, Cecil E, Majeed A, Pollok RC (2019) The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study. Aliment Pharmacol Ther 50(5):556\u2013567","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"11124_CR69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.26444\/aaem\/105821","volume":"27","author":"M Dziekiewicz","year":"2020","unstructured":"Dziekiewicz M, Kowalska-Duplaga K, Baranowska-Nowak M, Ne\u015bcioruk M, Ku\u017aniarski S, Banasiuk M, Banaszkiewicz A (2020) Awareness of smoking in adolescents with inflammatory bowel disease. Ann Agric Environ Med 27(1):61\u201365","journal-title":"Ann Agric Environ Med"},{"issue":"9","key":"11124_CR70","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092963","volume":"9","author":"MG Sublette","year":"2020","unstructured":"Sublette MG, Cross TW, Korcarz CE, Hansen KM, Murga-Garrido SM, Hazen SL, Wang Z, Oguss MK, Rey FE, Stein JH (2020) Effects of smoking and smoking cessation on the intestinal microbiota. J Clin Med 9(9):2963","journal-title":"J Clin Med"},{"issue":"1","key":"11124_CR71","volume":"28","author":"KC Tu","year":"2023","unstructured":"Tu KC, Yu RY, Lin YH, Chien CC, Lu CL (2023) Bidirectional association between infectious gastroenteritis and inflammatory bowel disease: a population-based study. Eur J Med Res 28(1):337","journal-title":"Eur J Med Res"},{"issue":"11","key":"11124_CR72","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700144","volume":"61","author":"A Rodr\u00edguez-Nogales","year":"2017","unstructured":"Rodr\u00edguez-Nogales A, Algieri F, Garrido\u2010Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodr\u00edguez\u2010Cabezas ME, Galvez J (2017) Differential intestinal anti\u2010inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on MicroRNAs expression and microbiota composition. Mol Nutr Food Res 61(11):1700144","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"11124_CR73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5217\/ir.2023.00080","volume":"22","author":"H Pandey","year":"2024","unstructured":"Pandey H, Jain D, Tang DW, Wong SH, Lal D (2024) Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease. Intest Res 22(1):15\u201343","journal-title":"Intest Res"},{"issue":"4","key":"11124_CR74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/intimm\/dxz078","volume":"32","author":"J Isobe","year":"2020","unstructured":"Isobe J, Maeda S, Obata Y, Iizuka K, Nakamura Y, Fujimura Y, Kimizuka T, Hattori K, Kim YG, Morita T, Kimura I (2020) Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon. Int Immunol 32(4):243\u2013258","journal-title":"Int Immunol"},{"issue":"26","key":"11124_CR75","doi-asserted-by":"crossref","first-page":"e42791","DOI":"10.1097\/MD.0000000000042791","volume":"104","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zheng X, Yang C, Shen W, Shen Z (2025) Gut microbiota causally affects ulcerative colitis by potential mediation of plasma metabolites: a Mendelian randomization study. Medicine (Baltimore) 104(26):e42791","journal-title":"Medicine (Baltimore)"},{"key":"11124_CR76","volume":"11","author":"J Xiao","year":"2024","unstructured":"Xiao J, Guo X, Lin Y, Wang Z (2024) The causal relationship between immune cell-mediated gut microbiota and ulcerative colitis: a bidirectional two-sample, mediation Mendelian randomization analysis. Front Nutr 11:1433545","journal-title":"Front Nutr"},{"key":"11124_CR77","doi-asserted-by":"crossref","first-page":"1304858","DOI":"10.3389\/fcimb.2023.1304858","volume":"13","author":"F Li","year":"2024","unstructured":"Li F, Yu C, Zhao Q, Wang Z, Wang Z, Chang Y, Xu Z, Han X, Li H, Liu Y, Hu S (2024) Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease. Front Cell Infect Microbiol 13:1304858","journal-title":"Front Cell Infect Microbiol"},{"key":"11124_CR78","doi-asserted-by":"crossref","first-page":"835058","DOI":"10.3389\/fmicb.2022.835058","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Zhang H, Wang S, Du Y, Wei B, Wu Q, Wang H (2022) Inhibitors of bacterial extracellular vesicles. Front Microbiol 13:835058","journal-title":"Front Microbiol"},{"key":"11124_CR79","doi-asserted-by":"crossref","first-page":"1411196","DOI":"10.3389\/fcimb.2024.1411196","volume":"14","author":"B Jiang","year":"2024","unstructured":"Jiang B, Huang J (2024) Influences of bacterial extracellular vesicles on macrophage immune functions. Front Cell Infect Microbiol 14:1411196","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"11124_CR80","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","volume":"156","author":"CW Ko","year":"2019","unstructured":"Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK, Crockett S, Feuerstein J, Flamm S, Inadomi J, Ko C (2019) AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis. Gastroenterology 156(3):748\u2013764","journal-title":"Gastroenterology"},{"issue":"1","key":"11124_CR81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12944-016-0245-0","volume":"15","author":"M Balfeg\u00f3","year":"2016","unstructured":"Balfeg\u00f3 M, Canivell S, Hanzu FA, Sala-Vila A, Mart\u00ednez-Medina M, Murillo S, Mur T, Ruano EG, Linares F, Porras N, Valladares S (2016) Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-na\u00efve patients with type 2 diabetes: a pilot randomized trial. Lipids Health Dis 15(1):78","journal-title":"Lipids Health Dis"},{"issue":"5","key":"11124_CR82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/17474124.2019.1596797","volume":"13","author":"OH Nielsen","year":"2019","unstructured":"Nielsen OH, Ainsworth MA, Steenholdt C (2019) Methotrexate for inflammatory bowel disease: time for reconsideration. Expert Rev Gastroenterol Hepatol 13(5):407\u2013409","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"11124_CR83","volume":"180","author":"W Chen","year":"2023","unstructured":"Chen W, Tan D, Yang Z, Tang J, Bai W, Tian L (2023) Fermentation patterns of prebiotics fructooligosaccharides-SCFA esters inoculated with fecal microbiota from ulcerative colitis patients. Food Chem Toxicol 180:114009","journal-title":"Food Chem Toxicol"},{"issue":"14","key":"11124_CR84","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","volume":"29","author":"S Roy","year":"2023","unstructured":"Roy S, Dhaneshwar S (2023) Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives. World J Gastroenterol 29(14):2078","journal-title":"World J Gastroenterol"},{"issue":"1","key":"11124_CR85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IM9.0000000000000046","volume":"3","author":"Y Liang","year":"2021","unstructured":"Liang Y, Liu M, Pu J, Zhu Z, Gao Z, Zhou Q, Gu Q, Li P (2021) Probiotics and their metabolites ameliorate inflammatory bowel disease: a critical review. Infect Microbes Dis 3(1):4\u201313","journal-title":"Infect Microbes Dis"},{"issue":"3","key":"11124_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.33073\/pjm-2023-025","volume":"72","author":"S Shang","year":"2023","unstructured":"Shang S, Zhu J, Liu X, Wang W, Dai T, Wang L, Li B (2023) The impacts of fecal microbiota transplantation from same sex on the symptoms of ulcerative colitis patients. Pol J Microbiol 72(3):247","journal-title":"Pol J Microbiol"},{"issue":"8","key":"11124_CR87","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4014\/jmb.2002.02044","volume":"30","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zou G, Li B, Du X, Sun Z, Sun Y, Jiang X (2020) Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation. J Microbiol Biotechnol 30(8):1132","journal-title":"J Microbiol Biotechnol"},{"issue":"9","key":"11124_CR88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238910","volume":"15","author":"LD Caldeira","year":"2020","unstructured":"Caldeira LD, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R (2020) Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis. PLoS ONE 15(9):e0238910","journal-title":"PLoS ONE"},{"key":"11124_CR89","volume":"85","author":"Y Wang","year":"2020","unstructured":"Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y (2020) Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 85:106661","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"11124_CR90","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1007\/s10620-016-4060-2","volume":"61","author":"Z Tian","year":"2016","unstructured":"Tian Z, Liu J, Liao M, Li W, Zou J, Han X, Kuang M, Shen W, Li H (2016) Beneficial effects of fecal microbiota transplantation on ulcerative colitis in mice. Dig Dis Sci 61(8):2262\u20132271","journal-title":"Dig Dis Sci"},{"issue":"6","key":"11124_CR91","doi-asserted-by":"crossref","first-page":"e0158227","DOI":"10.1371\/journal.pone.0158227","volume":"11","author":"T Zhang","year":"2016","unstructured":"Zhang T, Cui B, Li P, He Z, Long C, Wei L, Peng Z, Ji G, Zhang F (2016) Short-term surveillance of cytokines and C-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis. PLoS ONE 11(6):e0158227","journal-title":"PLoS ONE"},{"issue":"1","key":"11124_CR92","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5958\/0974-360X.2021.00101.3","volume":"14","author":"RT Mahmood","year":"2021","unstructured":"Mahmood RT, Shamim A, Ahsan F, Parveen S (2021) Foeniculum vulgare, solanum nigrum and cichorium intybus: a collectanea of pharmacological and clinical uses. Res J Pharm Technol 14(1):555\u2013561","journal-title":"Res J Pharm Technol"},{"issue":"1","key":"11124_CR93","first-page":"1","volume":"2","author":"R Wasim","year":"2024","unstructured":"Wasim R, Mahmood T, Shamim A, Ahsan F, Singh A (2024) Metaphorical investigation of aqueous distillate of cichorium intybus, foeniculum vulgare and solanum nigrum along with Atorvastatin and Orlistat in experimental rodent models of dyslipidaemia and obesity. Intell Pharm 2(1):1\u20131","journal-title":"Intell Pharm"},{"issue":"1","key":"11124_CR94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1319-3767.173753","volume":"22","author":"IM Balmus","year":"2016","unstructured":"Balmus IM, Ciobica A, Trifan A, Stanciu C (2016) The implications of oxidative stress and antioxidant therapies in inflammatory bowel disease: clinical aspects and animal models. Saudi J Gastroenterol 22(1):3\u201317","journal-title":"Saudi J Gastroenterol"},{"issue":"18","key":"11124_CR95","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161209788489177","volume":"15","author":"H Hanai","year":"2009","unstructured":"Hanai H, Sugimoto K (2009) Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15(18):2087\u20132094","journal-title":"Curr Pharm Des"},{"issue":"3","key":"11124_CR96","doi-asserted-by":"crossref","first-page":"151","DOI":"10.22271\/phyto.2022.v11.i3b.14404","volume":"11","author":"S Alyahya","year":"2022","unstructured":"Alyahya S, Arif M, Wasim R, Kushwaha SP (2022) Phoenix dactylifera L.(Ajwa Dates): an energetic plant fruit with immense nutraceuticals value for strengthening the power of resistance. J Pharmacognosy Phytochem 11(3):151\u2013162","journal-title":"J Pharmacognosy Phytochem"},{"issue":"4","key":"11124_CR97","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0007114511000390","volume":"106","author":"Q Jia","year":"2011","unstructured":"Jia Q, Ivanov I, Zlatev ZZ, Alaniz RC, Weeks BR, Callaway ES, Goldsby JS, Davidson LA, Fan YY, Zhou L, Lupton JR (2011) Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. Br J Nutr 106(4):519\u2013529","journal-title":"Br J Nutr"},{"key":"11124_CR98","doi-asserted-by":"crossref","unstructured":"Wasim R, Azmi S, Owais M, Anwar A (2025) Curcumin in type 2 diabetes mellitus: A natural approach to modulating metabolic dysfunction. Drug Res. Jun 2","DOI":"10.1055\/a-2604-4115"},{"issue":"1","key":"11124_CR99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, L\u00f6wenberg M, van den Brink GR, Mathus-Vliegen EM, de Vos WM, Zoetendal EG (2015) Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149(1):110\u2013118","journal-title":"Gastroenterology"},{"key":"11124_CR100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.intimp.2018.11.049","volume":"67","author":"L Zhu","year":"2019","unstructured":"Zhu L, Gu P, Shen H (2019) Gallic acid improved inflammation via NF-\u03baB pathway in TNBS-induced ulcerative colitis. Int Immunopharmacol 67:129\u2013137","journal-title":"Int Immunopharmacol"},{"key":"11124_CR101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yrtph.2019.03.006","volume":"104","author":"B Guven","year":"2019","unstructured":"Guven B, Can M, Piskin O, Aydin BG, Karakaya K, Elmas O, Acikgoz B (2019) Flavonoids protect colon against radiation induced colitis. Regul Toxicol Pharmacol 104:128\u2013132","journal-title":"Regul Toxicol Pharmacol"},{"issue":"10","key":"11124_CR102","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mnfr.201501042","volume":"60","author":"ZT Bitzer","year":"2016","unstructured":"Bitzer ZT, Elias RJ, Vijay-Kumar M, Lambert JD (2016) (\u2010)\u2010Epigallocatechin\u20103\u2010gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss. Mol Nutr Food Res 60(10):2267\u20132274","journal-title":"Mol Nutr Food Res"},{"key":"11124_CR103","doi-asserted-by":"crossref","first-page":"155408","DOI":"10.1016\/j.phymed.2024.155408","volume":"128","author":"F Wei","year":"2024","unstructured":"Wei F, Li D, Chen X, Li Y, Zeng Y, Cai Y, Zeng Y, Chen Y, Ma X, Zeng J (2024) Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: a preclinical meta-analysis. Phytomedicine 128:155408","journal-title":"Phytomedicine"},{"issue":"3","key":"11124_CR104","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.fshw.2021.12.008","volume":"11","author":"VL Truong","year":"2022","unstructured":"Truong VL, Jeong WS (2022) Antioxidant and anti-inflammatory roles of tea polyphenols in inflammatory bowel diseases. Food Sci Hum Wellness 11(3):502\u2013511","journal-title":"Food Sci Hum Wellness"},{"key":"11124_CR105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.redox.2015.10.006","volume":"6","author":"DC Montrose","year":"2015","unstructured":"Montrose DC, Horelik NA, Madigan JP, Stoner GD, Wang LS, Bruno RS, Moura FA, de Andrade KQ, Santos D, Ara\u00fajo JCF, O. R. P., Goulart MOF (2015) Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biol 6:617\u2013639","journal-title":"Redox Biol"},{"key":"11124_CR106","doi-asserted-by":"publisher","DOI":"10.17762\/jaz.v44iS-5.1509","author":"AM Mohamed","year":"2023","unstructured":"Mohamed AM, Shalaby MA, Ismail NS (2023) Anti-inflammatory and antioxidant effects of grapefruit juice on ulcerative colitis induced by acetic acid in rats. J Adv Zool. https:\/\/doi.org\/10.17762\/jaz.v44iS-5.1509","journal-title":"J Adv Zool"},{"issue":"4","key":"11124_CR107","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jcmgh.2019.11.011","volume":"9","author":"J Skupsky","year":"2020","unstructured":"Skupsky J, Sabui S, Hwang M, Nakasaki M, Cahalan MD, Said HM (2020) Biotin supplementation ameliorates murine colitis by preventing NF-\u03baB activation. Cell Mol Gastroenterol Hepatol 9(4):557\u2013567","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"11124_CR108","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jnutbio.2018.08.005","volume":"61","author":"A Rodriguez-Nogales","year":"2018","unstructured":"Rodriguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Rodr\u00edguez-Cabezas ME, Galvez J (2018) Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: impact on MicroRNAs expression and gut microbiota composition. J Nutr Biochem 61:129\u2013139","journal-title":"J Nutr Biochem"},{"issue":"1","key":"11124_CR109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12602-016-9239-5","volume":"9","author":"V Lor\u00e9n","year":"2017","unstructured":"Lor\u00e9n V, Many\u00e9 J, Fuentes MC, Cabr\u00e9 E, Ojanguren I, Espadaler J (2017) Comparative effect of the I3. 1 probiotic formula in two animal models of colitis. Probiotics Antimicrob Proteins 9(1):71\u201380","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"6","key":"11124_CR110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jiac.2020.01.006","volume":"26","author":"S Komaki","year":"2020","unstructured":"Komaki S, Haque A, Miyazaki H, Matsumoto T, Nakamura S (2020) Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice. J Infect Chemother 26(6):549\u2013553","journal-title":"J Infect Chemother"},{"issue":"1","key":"11124_CR111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bpg.2016.02.005","volume":"30","author":"LA Derikx","year":"2016","unstructured":"Derikx LA, Dieleman LA, Hoentjen F (2016) Probiotics and prebiotics in ulcerative colitis. Best Pract Res Clin Gastroenterol 30(1):55\u201371","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"11124_CR112","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jff.2019.02.002","volume":"54","author":"CB Wong","year":"2019","unstructured":"Wong CB, Odamaki T, Xiao JZ (2019) Beneficial effects of bifidobacterium longum subsp. longum BB536 on human health: modulation of gut microbiome as the principal action. J Funct Foods 54:506\u2013519","journal-title":"J Funct Foods"},{"issue":"10075","key":"11124_CR113","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RW, Connor S, Ng W, Paramsothy R, Xuan W (2017) Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389(10075):1218\u20131228","journal-title":"Lancet"},{"issue":"2","key":"11124_CR114","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, Katsikeros R, Makanyanga J, Campaniello MA, Mavrangelos C, Rosewarne CP (2019) Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 321(2):156\u2013164","journal-title":"JAMA"},{"key":"11124_CR115","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00002","volume":"9","author":"BC Wilson","year":"2019","unstructured":"Wilson BC, Vatanen T, Cutfield WS, O\u2019Sullivan JM (2019) The super-donor phenomenon in fecal microbiota transplantation. Front Cell Infect Microbiol 9:430737","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"11124_CR116","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","volume":"46","author":"MN Quraishi","year":"2017","unstructured":"Quraishi MN, Widlak M, Bhala NA, Moore D, Price M, Sharma N, Iqbal TH (2017) Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory clostridium difficile infection. Aliment Pharmacol Ther 46(5):479\u2013493","journal-title":"Aliment Pharmacol Ther"},{"key":"11124_CR117","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/MCG.0000000000000368","volume":"49","author":"R Chibbar","year":"2015","unstructured":"Chibbar R, Dieleman LA (2015) Probiotics in the management of ulcerative colitis. J Clin Gastroenterol 49:S50\u2013S55","journal-title":"J Clin Gastroenterol"},{"key":"11124_CR118","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.clnesp.2024.08.005","volume":"63","author":"V Shukla","year":"2024","unstructured":"Shukla V, Singh S, Verma S, Verma S, Rizvi AA, Abbas M (2024) Targeting the microbiome to improve human health with the approach of personalized medicine: latest aspects and current updates. Clin Nutr ESPEN 63:813\u2013820","journal-title":"Clin Nutr ESPEN"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11124-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11124-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11124-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:05:59Z","timestamp":1766898359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11124-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11124"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11124-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have given their consent for publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1006"}}